VUČIĆEV ZAOKRET KOJI JE SPASAO HILJADE: Srbija danas leči najteže bolesti
Brojke koje znače život
TL;DR
- Investments in innovative medicines and rare disease treatments in Serbia have increased multi-fold.
- From 2007-2012, Serbia invested 19.2 billion dinars in innovative medicines, while from 2013-2025, this figure rose to 218.7 billion dinars.
- Systemic treatment for rare diseases was virtually non-existent before 2012, with only 8 patients treated that year.
- By 2025, 930 patients, including children and adults, receive rare disease therapies.
- The number of children treated abroad for illnesses increased from 440 (2008-2012) to 5,873 (2013-2025).
- Within Serbia, the number of children treated for rare diseases grew from 8 in 2012 to 296 in 2025.
- Funding for rare disease therapies increased from 130 million dinars in 2012 to 10.2 billion dinars by 2026, an almost eighty-fold increase.
- This policy change, implemented during President Aleksandar Vučić's tenure, has provided hope and treatment to thousands of families.